Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) filed a Form 8-K with the Securities and Exchange Commission on February 12, 2026, disclosing a material event. Insight Molecular…
Insight Molecular Diagnostics Inc. (NASDAQ:IMDX) filed a Form 8-K with the Securities and Exchange Commission on February 12, 2026, disclosing a material event.
Insight Molecular Diagnostics Inc.'s stock currently trades at $5.58 with a market capitalization of $149.6M. The Healthcare company's stock moved following the disclosure.
Current market data
NASDAQ · IMDX
$4.01
Up: +$0.11 · +2.74%
Live quote updated
Our Markets Team monitors market data, SEC filings, analyst actions, earnings releases, and corporate announcements to produce timely updates for investors.
Keep reading
analyst ·
earnings ·
price ·
price ·
